⬆️ #CVD risks in #men & #women across #glycemic spectrum are largely explained by modifiable factors, could be ⬇️ by attention to #weight reduction & greater use of #antihypertensive and #statin ???? https://t.co/ndZaPkcUZQ #HTN #T2D #lipids @TheLancet @DrMarthaGulati @ErinMichos pic.twitter.com/yrCdGEid82
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 29, 2023
#DAPT #deescalation #switching #ticagrelor #clopidogrel ???? #bleeding ⬇️ @mmamas1973 @mirvatalasnag @VijayKunadian @ShrillaB @Drroxmehran @DFCapodanno @vlgmrc @gbiondizoccai @FeliceGragnano @DrMarthaGulati @DocSavageTJU @Hragy @SABOURETCardio @HanCardiomd @biljana_parapid https://t.co/XVmBKJe55e
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 23, 2023
As a community, members of #cardiology team have responsibility to speak up about inappropriate behaviour &responsibility to respond???? #bullying #support @AnastasiaSMihai @emorywomenheart @mirvatalasnag @gina_lundberg @gbiondizoccai @KardiologieHH @SABOURETCardio @ShelleyWood2 https://t.co/7yoQDPxJHd
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 19, 2023
#Inappropriate behaviour includes #discrimination, #harassment & #bullying. This includes both #actions & #language and can affect any member of #CV team???? https://t.co/5Durr0WaQS #WorkLifeBalance #CardioEd @cfcamm @mmamas1973 @DrMarthaGulati @JGrapsa @ErinMichos @VijayKunadian pic.twitter.com/0jqK2wzzeR
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 19, 2023
1️⃣in????pts who undergo #PCI as part of pre-#TAVI workup have late major #bleeding events that ⬆️ their risk for #death & #disability ???? https://t.co/OUAvwoRS0Y #DAPT @MAvvedimento @mmamas1973 @mirvatalasnag @gbiondizoccai @FeliceGragnano @VijayKunadian @ShrillaB @aayshacader pic.twitter.com/1Hf7a107fN
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 15, 2023
#women with #gestational #diabetes may have ⬆️ risk of total and #CV #mortality within 3️⃣0️⃣yrs following #delivery ???? https://t.co/4odAlVUG70 #pregnancy #T2D #CVD #CardioObstetrics @ErinMichos @DrMarthaGulati @mmamas1973 @mirvatalasnag @VijayKunadian @biljana_parapid @hvanspall pic.twitter.com/wfUO5pzRvn
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 12, 2023
Pts w/ #ANOCA often face ⬆️ burden of #symptoms & may experience repeated presentations to multiple #medical providers before receiving a #diagnosis ???? https://t.co/QaOCG6KWC5 #INOCA #coronary @mmamas1973 @mirvatalasnag @VijayKunadian @KemalogluOz @gbiondizoccai @InocaInternati1 pic.twitter.com/nNMXwABi1D
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 12, 2023
Growing insights into pathophysiology of acute #cardiorenal syndrome #CRS in acute decompensated #HF have indicated that not every ⬆️ in #creatinine is linked to adverse outcomes https://t.co/utBTIDCFgc #renal #CVD #HFrEF @PieterMartensMD @JACCJournals @mmamas1973 @VijayKunadian pic.twitter.com/Df9D5NVptS
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 11, 2023
Compared w/ #adolescents who always met #sleep recommendations, the prevalence of #overweight/#obesity was ∼5️⃣x⬆️ in those never meeting recommendations or meeting them only once. #CVD #CardioEd @BethFratesMD @gbiondizoccai @FeliceGragnano @JGrapsa @GiuseppeGalati_ @HanCardiomd pic.twitter.com/EtUqOun9xW
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 10, 2023
As few as 2️⃣6️⃣0️⃣0️⃣ & 2️⃣8️⃣0️⃣0️⃣ #steps/d yield significant #mortality & #CVD benefits, with progressive #risk ⬇️ up to 8️⃣8️⃣0️⃣0️⃣ &7️⃣2️⃣0️⃣0️⃣ ????/d, respectively https://t.co/fT4881qbQ2 #CVprev #lifestyle @DrMarthaGulati @ErinMichos @mmamas1973 @KemalogluOz @hvanspall @VijayKunadian pic.twitter.com/G5RrMmzSPi
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) September 10, 2023
Among #women with #premature #AMI, 4️⃣in???? had h/o adverse #pregnancy outcomes. Pregnancy outcomes may identify women who warrant early, aggressive #CVD #prevention ???? https://t.co/Ci2xTJb2dm #CVprev @JACCJournals @malamo512 @ErinMichos @DrMarthaGulati @hvanspall @mirvatalasnag pic.twitter.com/bfMr3mAoZL
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 25, 2023
Modifying #lifestyle #risk factors could prevent 41% of #AFib in #women and 14% of AFib in #men ???? https://t.co/SDEEgtMzcy #prevention #CVprev #obesity #excercise #HTN #BP @cpgale3 @DrMarthaGulati @ErinMichos @gina_lundberg @emorywomenheart @VijayKunadian @mmamas1973 @Hragy pic.twitter.com/RTHzsmzU17
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 23, 2023
#GDMTworks in #CTO ???? @DFCapodanno @EuroInterventio @PCRonline @DocSavageTJU @fischman_david @djc795 @ajaykirtane @alaide_chief @DrMarthaGulati @ErinMichos @biljana_parapid @mirvatalasnag @gbiondizoccai @SABOURETCardio @HeartBobH @HeartOTXHeartMD @JGrapsa @KardiologieHH @Hragy https://t.co/KjTeGDdios
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 22, 2023
findings suggest caution in claims linking regular #physical #exercise to #cognitive benefits in the #healthy persons until more reliable causal evidence accumulate https://t.co/Uv72qlGY4W #CVprev #fitness #workout @DrMarthaGulati @drjohnm @mmamas1973 @hvanspall @HeartOTXHeartMD pic.twitter.com/eWUi5Sdx6n
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 22, 2023
evidenced-based & #patient-centered approach to management of patients with chronic #coronary disease #CAD #CCS , considering #social determinants of #health & incorporating shared decision-making and team-based care https://t.co/BXQQiSa5qW @JACCJournals @ACCinTouch @AHAScience pic.twitter.com/THJCFfcSq9
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 21, 2023
#prevention & mamanament of #cardiometabolic risk ???? https://t.co/BqNuelP7vd #CVD #ASCVD #CVprev #inflammation #HTN #T2D #CKD @AndreasZeiher @DrMarthaGulati @SABOURETCardio @ErinMichos @mmamas1973 @VijayKunadian @HeartOTXHeartMD @biljana_parapid @DFCapodanno @gbiondizoccai @Hragy pic.twitter.com/7rjHTPSWAB
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 15, 2023
Benefits and risks of #vegetarian & #vegan #diets ???? https://t.co/2eir9sHn9q #CVD #CVprev #cardiometabolic #health #lipids #T2D #HTN @ehj_ed @escardio @ESC_Journals @DrMarthaGulati @gina_lundberg @ErinMichos @mmamas1973 @drjohnm @biljana_parapid @hvanspall @gbiondizoccai @Hragy pic.twitter.com/U7vimY7FRB
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 15, 2023
#PCI after #TAVI in pts w/ #AS & #CAD seems to be associated with improved 2-year clinical outcomes compared with other #revascularisztion timing strategies https://t.co/q9yXuFnuYc #CVD #CardioEd @PCRonline @DFCapodanno @CMichaelGibson @gbiondizoccai @mirvatalasnag @DocSavageTJU pic.twitter.com/2jhnKLhaH0
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 13, 2023
The role of #invasive #cardiac #interventions in pts with active, #cancer should be #EBM-based and nuanced and requires #CardioOncology expertise and multidisciplinary input https://t.co/CzEGdAUFVI #CVD #ACS #ICD #revasc @JACCJournals @DrMarthaGulati @hvanspall @ErinMichos @Hragy pic.twitter.com/LKlhCijr79
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 13, 2023
#Young #womem w #AMI have ⬆️ #adverse outcomes than #men during 1️⃣2️⃣mo after discharge. #CV hospitalizations were most common, but nonCV hospitalizations showed the most significant #sex #disparity https://t.co/qpZbzawKYa @JACCJournals @MitsuakiSawano @mirvatalasnag @hmkyale pic.twitter.com/CcAkUSUEdl
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 1, 2023
it’s important to understand why #women—and other groups—are currently #underrepresented in #RCTs. It’s essential to move from acknowledging gaps to closing them????#disparity #inequity #CVD @hvanspall @DrMarthaGulati @ShrillaB @ErinMichos @biljana_parapid @JGrapsa @mirvatalasnag https://t.co/bNj5R3EOzo pic.twitter.com/fGkvDCwcnQ
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 1, 2023
Among pts undergoing #LM #revascularization those with #ACS had ⬆️ rates of early #death. Rates of all-cause mortality through 5 years were ↔️ with #PCI vs #CABG ???? https://t.co/2gUixK3mbq #CAD @JAMACardio @PrakritiGaba @h_evald @BrianBergmark @mmamas1973 @mirvatalasnag @drjohnm pic.twitter.com/Qeh2AxqdLt
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) July 1, 2023
There is a substantial #global #burden of #CVD in #youths and #young #adults. The burden of overall and type-specific CVDs varied by #age, #sex, #sociodemographics, #region, and #country ???? https://t.co/FXmPsJksGs @BMCMedicine @mmamas1973 @hvanspall @kaulcsmc @drjohnm @Hragy pic.twitter.com/246lfirSnw
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 30, 2023
Individuals w/o #SMuRFs (#T2D, #HTN, #smoking, #hypercholesterolemia) presenting w/ #AMI have⬆️risk of all‐cause #mortality with ⬇️ prescription rate for #GDMT???? https://t.co/Zttc0apKaM #CVD #CVprev @zainchunawala @CaugheyPhD @DLBHATTMD @HeartOTXHeartMD @AqamarMD @mirvatalasnag pic.twitter.com/LeWRQJUbnI
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 29, 2023
#Angina or #ischemia with no obstructive coronary disease (#ANOCA/INOCA) is under-treated due to poorly understood pathophysiologic mechanisms, limited diagnostic tools, & lack of proven targeted therapy ???? https://t.co/Fol8uMcarc #CVD @AmericanHeartJ @OdaymeMD @mirvatalasnag pic.twitter.com/dJ5TAutcBC
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 29, 2023
Novel therapies are under investigation and include the #coronary #sinus #reducer, #CD34+ #stem cell therapy, and novel pharmacologic agents such as #sGC stimulators or #endothelin-receptor blockers???? #ANOCA #INOCA #CVD @OdaymeMD @mirvatalasnag @DLBHATTMD @HeartOTXHeartMD @Hragy https://t.co/wtHGcrAV5t pic.twitter.com/UGEhjKxqwW
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 29, 2023
Complex interacting factors, incl biological, clinical, and societal variables highlight #gender-related #inequities in the #diagnosis & #management of #PAD ????https://t.co/ujRE2VScCK #CVD #women #atherosclerosis @KavurmaMary @Drsarahaitken @mirvatalasnag @mmamas1973 @WomenAs1 pic.twitter.com/C6qgkuBlm7
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 28, 2023
#Retatrutide, a triple receptor agonist (#GIP, #GLP1, and #glucagon receptors) has an average of >2️⃣4️⃣% body #weight ⬇️ ???? https://t.co/KvoBszuLoj @NEJM #ADA2023 #obesity #overweight @SABOURETCardio @HeartOTXHeartMD @drjohnm @CMichaelGibson @DLBHATTMD @DrMarthaGulati @hvanspall pic.twitter.com/fKzrtoAZth
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 28, 2023
#INOCA endotypes and management ????@mmamas1973 @alaide_chief @TCTMD @DrMarthaGulati @DocSavageTJU @HanCardiomd @pabeda1 @KardiologieHH @mirvatalasnag @gbiondizoccai @biljana_parapid @ErinMichos @HanCardiomd @hvanspall https://t.co/akIqacJtks
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 28, 2023
#Bempedoic acid in 4206 #high_risk #primary #prevention pts 67% of whom had #T2D showed a 30% risk ⬇️ of #CV death, #MI, #stroke, #coronary #revasc ???? https://t.co/AotxinuwbH #CVD #lipids #CVprev #ADA2023 @SABOURETCardio @HeartOTXHeartMD @drjohnm @DrMarthaGulati @mirvatalasnag pic.twitter.com/jpf3LB9sze
— Bartosz Hudzik MD PhD FESC FACC (@BartoszHudzik) June 28, 2023